Juan‐Miguel Jimenez

547 citations

18 papers · 412 indexed · h-index 11

Organic Chemistry top 10%
- Synthesis and Reactions of Organic Compounds 2
Pharmacology top 10%
- Alkaloids: synthesis and pharmacology 3
- Inflammatory mediators and NSAID effects 3
Toxicology top 10%
Pharmacology top 10%
- Alkaloids: synthesis and pharmacology 3
- Inflammatory mediators and NSAID effects 3
Biotechnology
Oncology
- Cytokine Signaling Pathways and Interactions 6
Molecular Biology
- Protein Kinase Regulation and GTPase Signaling 4
- Protein Tyrosine Phosphatases 3
Complementary and alternative medicine
- Medicinal Plants and Neuroprotection 2
Genetics
- Estrogen and related hormone effects 2

Co-authors: M.-Lluı̈sa Bennasar Joan Bosch Michael F. T. Koehler Patrick G. Harran Cheol‐Min Park Paul A. Wender Jef K. De Brabander Blaise Lippa
Cited by: Organic Chemistry Pharmacology Toxicology
Journals: Journal of the American Chemical Society (1 paper)Journal of Medicinal Chemistry (5 papers)The Journal of Organic Chemistry (1 paper)
Partner nations: Spain United States Japan

In The Last Decade

Juan‐Miguel Jimenez

18 papers receiving 390 citations

Peers

Countries citing papers authored by Juan‐Miguel Jimenez

Since Specialization

Citations

This map shows the geographic impact of Juan‐Miguel Jimenez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan‐Miguel Jimenez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan‐Miguel Jimenez more than expected).

Fields of papers citing papers by Juan‐Miguel Jimenez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan‐Miguel Jimenez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan‐Miguel Jimenez. The network helps show where Juan‐Miguel Jimenez may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Juan‐Miguel Jimenez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Juan‐Miguel Jimenez Line = papers co-authored together Juan‐Miguel Jimenez links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases Journal of Medicinal Chemistry ·Oscar Mammoliti,Sébastien L. X. Martina,Pieter Claes,Ghjuvanni Coti,Roland Blanqué,Catherine Jagerschmidt,Kenji F. Shoji,Monica Borgonovi,Steve De Vos,Florence Marsais,Line Oste,Evelyne M. Quinton,Miriam López‐Ramos,David Amantini,Reginald Brys,Juan‐Miguel Jimenez,René Galien,Steven Van der Plas	2024	5
2	Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis ACS Medicinal Chemistry Letters ·Philip N. Collier,Heather Twin,Ronald M. A. Knegtel,Dean Boyall,Guy Brenchley,Christopher J. Davis,Shazia Keily,Chau Mak,Andrew T. Miller,Françoise Y. T. M. Pierard,Luca Settimo,Clare Bolton,Peter Chiu,Adam P. Curnock,Elisabeth Doyle,Adam Tanner,Juan‐Miguel Jimenez	2019	9
3	Selective protein kinase Cθ (PKCθ) inhibitors for the treatment of autoimmune diseases Biochemical Society Transactions ·Adam P. Curnock,Clare Bolton,Pky Chiu,Elisabeth Doyle,Damien Fraysse,Matthias Hesse,Julie Jones,Peter Weber,Juan‐Miguel Jimenez	2014	10
4	Design and Optimization of Selective Protein Kinase C θ (PKCθ) Inhibitors for the Treatment of Autoimmune Diseases Journal of Medicinal Chemistry ·Juan‐Miguel Jimenez,Dean Boyall,Guy Brenchley,Philip N. Collier,Christopher J. Davis,Damien Fraysse,Shazia Keily,Jaclyn L. Henderson,Andrew T. Miller,Françoise Y. T. M. Pierard,Luca Settimo,Heather Twin,Claire M. Bolton,Adam P. Curnock,Pky Chiu,Adam Tanner,Stephen Young	2013	34
5	Structure-based optimization of aminopyridines as PKCθ inhibitors Bioorganic & Medicinal Chemistry Letters ·Juan‐Miguel Jimenez,Christopher J. Davis,Dean Boyall,Damien Fraysse,Ronald M. A. Knegtel,Luca Settimo,Stephen Young,Claire M. Bolton,Pky Chiu,Adam P. Curnock,Richele K. Rasmussen,Adam Tanner,I. R. Ager	2012	10
6	Discovery and Structure−Activity Relationship of 3-Aminopyrid-2-ones as Potent and Selective Interleukin-2 Inducible T-Cell Kinase (Itk) Inhibitors Journal of Medicinal Chemistry ·Jean‐Damien Charrier,Andrew T. Miller,David P. Kay,Guy Brenchley,Heather Twin,Philip N. Collier,Sharn Ramaya,Shazia Keily,Steven J. Durrant,Ronald M. A. Knegtel,Adam Tanner,Kieron Brown,Adam P. Curnock,Juan‐Miguel Jimenez	2011	46
7	Synthesis of a Stable Pyridyl Boronate and Its Reaction with Aryl and Heteroaryl Halides Heterocycles ·Joanne L. Pinder,Steven J. Durrant,Jean‐Damien Charrier,Juan‐Miguel Jimenez,Guy Brenchley,Philip N. Collier,David P. Kay,Andrew T. Miller,Françoise Y. T. M. Pierard,Sharn Ramaya,Shazia Sadiq,Heather Twin	2006	3
8	Synthesis and Biological Evaluation of 2-Phenylpyran-4-ones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors Journal of Medicinal Chemistry ·Francisco Caturla,Juan‐Miguel Jimenez,Núria Godessart,M. Amat,Á. de Pablo Cárdenas,Lı́dia Soca,Jordi Beleta,Hamish Ryder,M. Crespo	2004	28
9	Naphthalene derivatives: A new series of selective cyclooxygenase-2 inhibitors Bioorganic & Medicinal Chemistry Letters ·Joan Feixas,Juan‐Miguel Jimenez,Núria Godessart,Carles Puig,Lı́dia Soca,M. Crespo	2001	10
10	Nucleophilic Addition of 1-Acetylindole Enolates to Pyridinium Salts. Stereoselective Formal Synthesis of (±)-Geissoschizine and (±)-Akagerine via 1,4-Dihydropyridines The Journal of Organic Chemistry ·M.-Lluı̈sa Bennasar,Juan‐Miguel Jimenez,Bernat Vidal,Bilal A. Sufi,Joan Bosch	1999	36
11	Synthesis and Biological Evaluation of 3,4-Diaryloxazolones: A New Class of Orally Active Cyclooxygenase-2 Inhibitors Journal of Medicinal Chemistry ·Carles Puig,M. Crespo,Núria Godessart,Joan Feixas,Javier Ibarzo,Juan‐Miguel Jimenez,Lı́dia Soca,Ignasi Cardelús,Ascensión Heredia,Montserrat Miralpeix,Jaume Puig,Jordi Beleta,José María Huerta,Manel López,Vı́ctor Segarra,Hamish Ryder,José Palacios	1999	86
12	Synthesis of the First Members of a New Class of Biologically Active Bryostatin Analogues Journal of the American Chemical Society ·Paul A. Wender,Jef K. De Brabander,Patrick G. Harran,Juan‐Miguel Jimenez,Michael F. T. Koehler,Blaise Lippa,Cheol‐Min Park,Makoto Shiozaki	1998	82
13	The chemistry-medicine continuum: Synthetic, computer, spectroscopic and biological studies on new chemotherapeutic leads Pure and Applied Chemistry ·Paul A. Wender,Yolanda Martín-Cantalejo,Andrew J. Carpenter,Anna Chiu,Jef K. De Brabander,Patrick G. Harran,Juan‐Miguel Jimenez,Michael F. T. Koehler,Blaise Lippa,J. A. Morrison,Stephan Müller,Stephan N. Müller,Cheol‐Min Park,Makoto Shiozaki,Carsten Siedenbiedel,Donald J. Skalitzky,Masahiro Tanaka,Kazuhiro Irie	1998	11
14	The effect of lithium iodide on the acid-promoted cyclization of 4-[(1-indolylcarbonyl)methyl]-1,4-dihydropyridines Tetrahedron Letters ·M.-Lluı̈sa Bennasar,Juan‐Miguel Jimenez,Bilal A. Sufi,Joan Bosch	1996	9
15	A concise, stereoselective synthesis of (±)-geissoschizine Tetrahedron Letters ·M.-Lluı̈sa Bennasar,Juan‐Miguel Jimenez,Bilal A. Sufi,Joan Bosch	1996	17
16	A new synthetic entry to the alkaloids of the mavacurine group. First total synthesis of (±)-2,7-dihydropleiocarpamine Journal of the Chemical Society Chemical Communications ·Juan‐Miguel Jimenez,Ester Zulaica,M.-Lluı̈sa Bennasar,Joan Bosch	1993	8
17	Studies On the Synthesis of Mavacurine Type Alkaloids. Synthesis of 6a-Homopleiocarpamine Natural product letters ·M.-Lluı̈sa Bennasar,Ester Zulaica,Juan‐Miguel Jimenez,Joan Bosch	1992	2
18	An alternative synthesis of the indole alkaloid vinoxine Tetrahedron Letters ·M.-Lluı̈sa Bennasar,Ester Zulaica,Juan‐Miguel Jimenez,Joan Bosch	1990	6

About Juan‐Miguel Jimenez

Juan‐Miguel Jimenez is a scholar working on Pharmacology, Organic Chemistry and Complementary and alternative medicine, having authored 18 papers that have together received 412 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (6 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Protein Tyrosine Phosphatases (3 papers), Alkaloids: synthesis and pharmacology (3 papers), Inflammatory mediators and NSAID effects (3 papers), Medicinal Plants and Neuroprotection (2 papers), Synthesis and Reactions of Organic Compounds (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Organic Chemistry (294 citations), Pharmacology (104 citations) and Toxicology (19 citations). Juan‐Miguel Jimenez has collaborated with scholars based in Spain, United States and Japan. Frequent co-authors include M.-Lluı̈sa Bennasar, Joan Bosch, Michael F. T. Koehler, Patrick G. Harran, Cheol‐Min Park, Paul A. Wender, Jef K. De Brabander, Blaise Lippa, M. Crespo and Núria Godessart. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact